{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:42:47Z","timestamp":1780105367688,"version":"3.54.0"},"reference-count":32,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.brainres.2014.04.014","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T11:08:03Z","timestamp":1397819283000},"page":"82-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["PAR2-mediated epigenetic upregulation of \u03b1-synuclein contributes to the pathogenesis of Parkinson\u05f3s disease"],"prefix":"10.1016","volume":"1565","author":[{"given":"Ping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-mei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2014.04.014_bib1","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.4049\/jimmunol.179.8.5493","article-title":"Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer\u05f3s disease","volume":"179","author":"Afkhami-Goli","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2014.04.014_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/BST0380493","article-title":"Synaptic dysfunction in Parkinson\u05f3s disease","volume":"38","author":"Bagetta","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.brainres.2014.04.014_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u05f3s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2014.04.014_bib4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u05f3s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2014.04.014_bib5","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1523\/JNEUROSCI.4181-12.2013","article-title":"Nuclear factor kappaB-dependent histone acetylation is specifically involved in persistent forms of memory","volume":"33","author":"Federman","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.04.014_bib6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.mp.4000458","article-title":"Lewy body diseases and multiple system atrophy as alpha-synucleinopathies","volume":"3","author":"Goedert","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2014.04.014_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2014.04.014_bib8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.brainres.2014.04.014_bib9","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2014.04.014_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","article-title":"Extracellular alpha-synuclein-a novel and crucial factor in Lewy body diseases","volume":"10","author":"Lee","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2014.04.014_bib11","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.bjp.0704401","article-title":"Modulation of cardiac activity by tachykinins in the rat substantia nigra","volume":"134","author":"Lessard","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2014.04.014_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.brainres.2014.04.014_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/aps.2013.128","article-title":"Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-kappaB pathway","volume":"35","author":"Ma","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.brainres.2014.04.014_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2014.01.007","article-title":"Beneficial effects of early environmental enrichment on motor development and spinal cord plasticity in a rat model of cerebral palsy","volume":"263","author":"Marques","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2014.04.014_bib15","doi-asserted-by":"crossref","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson\u05f3s disease: features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.brainres.2014.04.014_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/npp.2012.124","article-title":"Histone regulation in the CNS: basic principles of epigenetic plasticity","volume":"38","author":"Maze","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2014.04.014_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1124\/jpet.111.190868","article-title":"Compromising sigma-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-kappaB\/Bcl-2-dependent mechanism: potential relevance to Parkinson\u05f3s disease","volume":"341","author":"Mori","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2014.04.014_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.20052148","article-title":"Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"203","author":"Noorbakhsh","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainres.2014.04.014_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0070-2153(04)60002-0","article-title":"Alpha-synuclein: normal function and role in neurodegenerative diseases","volume":"60","author":"Norris","year":"2004","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.brainres.2014.04.014_bib20","doi-asserted-by":"crossref","first-page":"12802","DOI":"10.1523\/JNEUROSCI.0898-11.2011","article-title":"Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons","volume":"31","author":"Peng","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.04.014_bib21","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u05f3s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.brainres.2014.04.014_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2013.04.056","article-title":"NF-kappaB activity is inversely correlated to RNF11 expression in Parkinson\u05f3s disease","volume":"547","author":"Pranski","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2014.04.014_bib23","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson\u05f3s disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2014.04.014_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-cellbio-101011-155818","article-title":"The membrane fusion enigma: SNAREs, Sec1\/Munc18 proteins, and their accomplices\u2014guilty as charged?","volume":"28","author":"Rizo","year":"2012","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.brainres.2014.04.014_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00281-011-0289-1","article-title":"Protease-activated receptor 2 signaling in inflammation","volume":"34","author":"Rothmeier","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.brainres.2014.04.014_bib26","doi-asserted-by":"crossref","first-page":"e38113","DOI":"10.1371\/journal.pone.0038113","article-title":"Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson\u05f3s disease","volume":"7","author":"Roy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2014.04.014_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2014.01.043","article-title":"Epigenetic modifications in the nervous system and their impact upon cognitive impairments","volume":"80C","author":"Rudenko","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2014.04.014_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14336\/AD.2014.050027","article-title":"Emerging candidate biomarkers for Parkinson\u05f3s disease: a review","volume":"5","author":"Saracchi","year":"2014","journal-title":"Aging Dis."},{"key":"10.1016\/j.brainres.2014.04.014_bib29","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1523\/JNEUROSCI.2581-13.2014","article-title":"Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson\u05f3s disease","volume":"34","author":"Spinelli","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2014.04.014_bib30","doi-asserted-by":"crossref","first-page":"e66743","DOI":"10.1371\/journal.pone.0066743","article-title":"Distinctive G protein-dependent signaling by protease-activated receptor 2 (PAR2) in smooth muscle: feedback inhibition of RhoA by cAMP-independent PKA","volume":"8","author":"Sriwai","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2014.04.014_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10571-013-9948-1","article-title":"Involvement of NF Kappa B in potentiated effect of Mn-containing dithiocarbamates on MPP(+) induced cell death","volume":"33","author":"Williams","year":"2013","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2014.04.014_bib32","article-title":"Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice","author":"Yabuki","year":"2013","journal-title":"Neuroscience"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899314005125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899314005125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T17:01:28Z","timestamp":1538672488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899314005125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":32,"alternative-id":["S0006899314005125"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2014.04.014","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAR2-mediated epigenetic upregulation of \u03b1-synuclein contributes to the pathogenesis of Parkinson\u05f3s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2014.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}